The Naicons' team

What differentiates us from our competitors is our people and our purpose. To get to know us, just keep reading.

 

The Naicons' team

What differentiates us from our competitors is our people and our purpose. To get to know us, just keep reading.

Stefano Donadio, PhD

Founder, CEO, & President of the Board

Founder and CEO. Over 30-year industrial experience in large, medium-size and startup companies involved in antibiotic discovery and development. His experience spans from drug discovery and development to company creation and management. He has contributed to developing the production processes for dalbavancin (marketed in 2014) and ramoplanin (in phase III clinical studies). He is the author of over 140 publications and patent applications in the fields of antibiotics and antibiotic-producing bacteria. He holds a degree in Chemistry from The University of Naples, Italy, with post-doctoral experience at Johns Hopkins University and The University of Wisconsin-Madison.

Sonia Maffioli, PhD

Co-Founder, & Chemistry Director

Co-Founder and Chemistry Director. Over 20-year industrial experience in medium-size and startup companies involved in antibiotic discovery and development. Her experience spans from early drug discovery to the development of drug candidates. She is the author of over 40 publications and patent applications in the fields of drug discovery. She holds a Chemistry degree with post-graduate training in Synthetic Chemistry from The University of Milan.

Margherita Sosio, PhD

Co-founder, Microbiology Director, & Board Member

Margherita Sosio is co-founder and Microbiology Director at Naicons Srl. She brings more than 30 years of senior-level leadership experience in medium-size and startup companies involved in antibiotic discovery and development. Her experience spans from technology development to screening to optimization of production processes. She has authored over 80 publications and patent applications in the field of antibiotics. She holds a degree in Agricultural Sciences from the University of Milan, with post-doctoral experience at ETH, Zürich.

Ermenegildo Beghè

Co-Founder, CFO, & Board Member

Co-founder and CFO. He has a consolidated experience in finance, controlling, project management, organization, and M&A. Over the past ten years he has been a financial and strategic advisor for several companies in various fields of business. He served previously as CFO in two high tech listed companies, Brainpower and Biosearch, where he also contributed to very successful deals. He holds a degree in economics from Bocconi University, Milan.

Marco Brughera, DVM

Board Member

Dr. Brughera is Group CEO of Leadiant Biosciences a global fully integrated Orphan/Rare Disease company. He previously has held several positions for the Sigma-Tau Group, including Corporate R&D Managing Director. He drove the commercial revival of a lead oncology product line resulting in its successful sale for a total of around $900M. He also successfully out-licensed the Defibrotide US rights to Jazz Pharmaceuticals.

CONTACT US